Research and Clinical Trials

Title  
SURTAVI
Brief Description  
The purpose of this study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic aortic stenosis (AS), and who have an intermediate surgical risk. Enrolled patients will either receive TAVI or Surgical Aortic Valve Replacement (SAVR).
Who may be Eligible  
Patients who have symptomatic severe Aortic Stenosis who are determined by the Heart Team to be at intermediate surgical risk.
Start Date  
12/04/2013
IRB Number  
12-13-04A
Principal Investigator  
Rinaldi, Michael
Contact Name  
Sally

For More Information, Contact  Sally  , Krueger
Phone:  (704) 355-4797  Fax:  (704) 355-7264  
Email:  SHVICliinicalResearch@carolinashealthcare.org
Address:1001 Blythe Blvd., MCP M-201 Charlotte, NC 28203
Close